Akiyoshi Kumiko | Department Of Internal Medicine I School Of Medicine Oita University

スポンサーリンク

概要

• AKIYOSHI Kumikoの詳細を見る
• 同名の論文著者
• Department Of Internal Medicine I School Of Medicine Oita Universityの論文著者

関連著者

• Hara Masahide

  Department Of Internal Medicine I School Of Medicine Oita Medical University

• Akiyoshi Kumiko

  Department Of Internal Medicine I School Of Medicine Oita University

• Akimitsu Tadafumi

  Department Of Internal Medicine I School Of Medicine Oita University

• Hara Masahide

  Department Of Internal Medicine 1 Faculty Of Medicine Oita University

• Hara Masahide

  Department of Internal Medicine 1, Faculty of Medicine, Oita University

• Saikawa Tetsunori

  Department Of Cardiovascular Science Oita University

• Saikawa Tetsunori

  Department Of Cardiovascular Science Faculty Of Medicine Oita University

• Saikawa Tetsunori

  First Department Of Internal Medicine Medical College Of Oita

• Akimitsu Tadafumi

  Department of Internal Medicine, School of Medicine, Oita Medical University

• Akiyoshi Kumiko

  Department of Internal Medicine I, School of Medicine, Oita Medical University

• Saikawa Tetsunori

  Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University

• Saikawa Tetsunori

  Department of Laboratory Examination and Diagnostics, Faculty of Medicine, Oita University

• Sakata Toshiie

  大分医科大学 臨床検査医

• Saikawa Tetsunori

  大分赤十字病院 循環器科

• Yoshimatsu Hironobu

  Department Of Internal Medicine 1 Oita University

• Yoshimatsu Hironobu

  Department Of Anatomy Biology And Medicine (internal Medicine (i)) Faculty Of Medicine Oita Universi

• Saikawa Tetsunori

  Laboratory and Diagnostic Medicine, Faculty of Medicine, Oita University

• SAKATA Toshiie

  the First Department of Internal Medicine

• Hara Masahide

  Department Of Internal Medicine I Faculty Of Medicine Oita University

もっと見る 閉じる

著作論文

• Pravastatin attenuates leukocyte adhesion and inhibits proinflammatory cytokine production after ischemia/reperfusion by regulationg angiotensin II
• Spironolactone prevents leukocyte-endothelium interaction induced by schemia-reperfusion and regulates plasma angiotensin II
• AT_1 Receptor Blockade Prevents Microvascular Dysfunction Induced by Ischemia/Reperfusion Injury

スポンサーリンク